A continuous-flow left ventricular assist device implant is a well-established therapy for patients with end-stage heart failure. Currently, the HeartMate 3 device is the only commercially available durable left ventricular assist device. Therefore, patients on HeartWare HVAD support who require a pump exchange must have a HeartMate 3 implanted.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1510/mmcts.2022.090 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!